# Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan

> **NCT03086226** · PHASE2 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 104 (actual)

## Conditions studied

- Mycetoma

## Interventions

- **DRUG:** Fosravuconazole
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT03086226
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-09
- **Primary completion:** 2021-06-10
- **Final completion:** 2022-03-07
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2024-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03086226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03086226, "Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03086226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*